Studies on the development of natural immunity to poliomyelitis in Louisiana. III. The serologic response to commercially produced "Salk vaccine" of children totally or partially susceptible to poliovirus infection.
D006801:Humans; D007113:Immunity, Innate; D008145:Louisiana; D011051:Poliomyelitis / Q000276:immunology*; D017955:Poliovirus; D011054:Poliovirus Vaccine, Inactivated
D011054:Poliovirus Vaccine, Inactivated
POLIOMYELITIS/immunology